Assertio Holdings, Inc. (ASRT)
11.56
+0.08
(+0.65%)
USD |
NASDAQ |
Jan 22, 16:00
11.56
0.00 (0.00%)
After-Hours: 20:00
Assertio Holdings Research and Development Expense (TTM): 2.49M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Perspective Therapeutics, Inc. | 61.22M |
| Altimmune, Inc. | 67.72M |
| Actinium Pharmaceuticals, Inc. | 20.82M |
| Aldeyra Therapeutics, Inc. | 35.99M |
| Myomo, Inc. | 6.879M |